Refractory Desmoplastic Small Round Cell Tumor
3 clinical trials · Condition
◉ Watch Refractory Desmoplastic Small Round Cell Tumor
| Record | Firm | Date |
|---|---|---|
| Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor (NCT04616560) | National Cancer Institute (NCI) | 2021-03-08 |
| Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults (NCT04530487) | M.D. Anderson Cancer Center | 2020-08-19 |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients (NCT04213794) | Mayo Clinic | 2019-11-08 |
Track Refractory Desmoplastic Small Round Cell Tumor automatically
Every clearance here is in the API, with alerts when new ones post.